PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome.
Saved in:
| Title: | PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. |
|---|---|
| Authors: | Beck, David B.1 (AUTHOR) david.beck@nyulangone.org, Heiblig, Maël2,3 (AUTHOR), Savic, Sinisa3,4 (AUTHOR), Ferrada, Marcela A.4,5 (AUTHOR), Mekinian, Arsène5,6 (AUTHOR), Chowdhury, Onima6,7,8 (AUTHOR), Hammond, Danielle7,9 (AUTHOR), Weeks, Lachelle D.8,10 (AUTHOR), Gurnari, Carmelo9,11,12 (AUTHOR), Kirino, Yohei10,13 (AUTHOR), Georgin-Lavialle, Sophie11,14,15,16,17 (AUTHOR), Buckley, Sarah A.12,18 (AUTHOR), Garcha, Raman13,18 (AUTHOR), Harder, Bryan G.14,18 (AUTHOR), Koster, Matthew J.15,19 (AUTHOR) |
| Source: | Journal of Clinical Medicine. Feb2026, Vol. 15 Issue 4, p1426. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20770383 |
|---|---|
| DOI: | 10.3390/jcm15041426 |
